Grens tussen spam en content vervaagt bij zoekmachines Zoekmachinespammers lijken de strijd te winnen van de techbedrijven, zo laat een nieuw wetenschappelijk onderzoek zien. De opkomst van AI zal die nadelige...
Nieuwe regels van de Europese Unie voor gezondheids-technologiebeoordelingen van kracht De EMA is klaar om de implementatie van de nieuwe regelgeving voor gezondheids-technologiebeoordeling (HTAR) (Verordening (EU)...
COVID-19 vaccine Moderna’s chief executive officer Stéphane Bancel (pictured above) said that he expects Moderna to be ready to submit its COVID-19 vaccine candidate to the US Food and Drug Administration (FDA) in...
6 Ways To Elevate the Text-to-Audio Experience for Your Content Converting your text-based, long-form content into audio versions sounds like an easy – and smart – thing to do. Don’t think you can just plug and play an...
Dit gebeurt er elke 60 seconden online in 2021 Het gebruik van internet en social media zit al jaren in een stijgende lijn. We appen, streamen, liken en delen 24 uur per dag en 7 dagen per week. Internet en alle...
PBM trade group ad campaign The Pharmaceutical Care Management Association (PCMA) is back with another seven-figure ad campaign challenging Big Pharma. PCMA released two 30-second ads Tuesday, with the campaign...
Informa Markets in India introduces Aesthetic and Anti-Aging Event of the year AMWC India 2023 The Aesthetic and Anti-Aging Medicine World Congress (AMWC) is set to make a remarkable debut in India with AMWC India 2023...
With its once-biggest seller Velcade bracing for generics, Takeda’s hoping to grow its follow-up drug Ninlaro into a blockbuster. But the drug fell short in a systemic light-chain AL amyloidosis analysis—and the company...
British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.
Sanofi has announced positive phase 3 data showing that nearly three times as many Dupixent patients experienced lower rates of itching and skin lesions at 24 weeks compared to the placebo. Detailed positive results...
We gebruiken cookies om ervoor te zorgen dat onze website zo soepel mogelijk draait. Als u doorgaat met het gebruiken van de website, gaan we er vanuit dat u ermee instemt.